ALDOA and hepatocellular carcinoma: Finally, we constructed prognostic nomograms based on ALDOA mRNA expression and TNM stage, and the calibration plot showed that the nomogram prediction was in excellent agreement with the probability of HCC patient survival (1-, 3-, and 5-years of OS), confirming that ALDOA expression could predict the clinical outcome of HCC patients (Fig. 7D).